Biomass smoke–associated lung diseases

Purpose of Review The aim of our review is to describe biomass-related lung diseases and their different phenotypes, associations, challenges in diagnosis, and treatment options. Recent Findings People over 60 years and exposed to high biomass smoke had higher odds of having respiratory morbidity. Approximately 30% of biomass smoke–exposed individuals have pulmonary function testing abnormalities. Biomass exposure increases the risk of developing COPD. Indacaterol and tiotropium may be recommended as a first line of treatment for biomass associated COPD. Liquid petroleum gas, improving cookstoves, or improving indoor ventilation can improve lung function. Summary Three billion worldwide are exposed to biomass fuel, predominantly in rural areas, leading to a large disease burden. Biomass-associated lung diseases can vary from increased respiratory infections, asthma, COPD, bronchiectasis, right middle lobe syndrome, and interstitial lung disease.